Cargando…

Corrigendum: Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating Pi3K/AKT pathway through the Serpinc1 gene

Detalles Bibliográficos
Autores principales:	Zhang, Jun, Tang, Zhijia, Guo, Xi, Wang, Yunxia, Zhou, Yuhong, Cai, Weimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643161/ https://www.ncbi.nlm.nih.gov/pubmed/38023118 http://dx.doi.org/10.3389/fonc.2023.1303608

Ejemplares similares

Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating the Pi3K/AKT pathway through the Serpinc1 gene
por: Zhang, Jun, et al.
Publicado: (2022)

SerpinC1/Antithrombin III in kidney-related diseases
por: Lu, Zeyuan, et al.
Publicado: (2017)

Utility of the SERPINC1 Gene Test in Ischemic Stroke Patients With Antithrombin Deficiency
por: Kim, Seondeuk, et al.
Publicado: (2022)

Identification and characterization of two SERPINC1 mutations causing congenital antithrombin deficiency
por: Wang, Han-lu, et al.
Publicado: (2023)

Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases
por: Ceelen, Wim, et al.
Publicado: (2022)

Antithrombin III/SerpinC1 insufficiency exacerbates renal ischemia/reperfusion injury
por: Wang, Feng, et al.
Publicado: (2015)

Case report: A case of new mutation in SERPINC1 leading to thrombotic microangiopathy
por: Li, Bing, et al.
Publicado: (2023)

Urine SERPINC1/ORM1 as biomarkers for early detection of lupus nephritis in MRL-lpr mice
por: Kim, Young-Eun, et al.
Publicado: (2023)

Corrigendum: Berberine and Oligomeric Proanthocyanidins Exhibit Synergistic Efficacy Through Regulation of PI3K-Akt Signaling Pathway in Colorectal Cancer
por: Okuno, Keisuke, et al.
Publicado: (2022)

Inherited antithrombin deficiency caused by a mutation in the SERPINC1 gene: A case report
por: Hou, Xinwei, et al.
Publicado: (2022)

Acquired SERPINC1/antithrombin deficiency during oral contraceptive consumption: a case report
por: Denora, D., et al.
Publicado: (2023)

Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency
por: Toderici, Mara, et al.
Publicado: (2016)

Recurrent mutations in a SERPINC1 hotspot associate with venous thrombosis without apparent antithrombin deficiency
por: Zeng, Wei, et al.
Publicado: (2017)

Association of SERPINC1 Gene Polymorphism (rs2227589) With Pulmonary Embolism Risk in a Chinese Population
por: Yue, Yongjian, et al.
Publicado: (2019)

ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K/AKT pathway in glioma
por: Xi, Xiaonan, et al.
Publicado: (2019)

The synergistic antitumor activity of 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) and anti-PD-L1 antibody inducing immunogenic cell death
por: Duan, Xiao-Chuan, et al.
Publicado: (2021)

Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer
por: Woo, S-U, et al.
Publicado: (2017)

Correction: Recurrent mutations in a SERPINC1 hotspot associate with venous thrombosis without apparent antithrombin deficiency
por: Zeng, Wei, et al.
Publicado: (2018)

A small deletion in SERPINC1 causes type I antithrombin deficiency by promoting endoplasmic reticulum stress
por: Su, Jingjing, et al.
Publicado: (2016)

Correction: Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency
por: Toderici, Mara, et al.
Publicado: (2016)

Novel Mutation p.Asp374Val of SERPINC1 in a Turkish Family with Inherited Antithrombin Deficiency
por: Aslan, Deniz
Publicado: (2021)

Antithrombin Deficiency Is Associated with a Novel Homozygous Detrimental Mutation in SERPINC1 Gene in a Saudi Female
por: Alqarni, Sana, et al.
Publicado: (2023)

Corrigendum: PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases
por: Ramirez, Giuseppe A., et al.
Publicado: (2019)

LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance
por: Zhai, Xiangyu, et al.
Publicado: (2022)

Mobilization of Circulating Tumor Cells after Short- and Long-Term FOLFIRINOX and GEM/nab-PTX Chemotherapy in Xenograft Mouse Models of Human Pancreatic Cancer
por: Ito, Yukako, et al.
Publicado: (2023)

Upregulation of MTHFD2 is associated with PD-L1 activation in bladder cancer via the PI3K/AKT pathway
por: Deng, Xinxi, et al.
Publicado: (2022)

Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092
por: Yu, Yi, et al.
Publicado: (2015)

CD155 Cooperates with PD-1/PD-L1 to Promote Proliferation of Esophageal Squamous Cancer Cells via PI3K/Akt and MAPK Signaling Pathways
por: Tang, Xiyang, et al.
Publicado: (2022)

Immune‐independent acquired resistance to PD‐L1 antibody initiated by PD‐L1 upregulation via PI3K/AKT signaling can be reversed by anlotinib
por: Gao, Yuan, et al.
Publicado: (2023)

A novel variation of SERPINC1 caused deep venous thrombosis in a Chinese family: A case report
por: Peng, Yu, et al.
Publicado: (2019)

Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays
por: de la Morena-Barrio, Maria Eugenia, et al.
Publicado: (2022)

Argatroban Resistance and Successful Adjunctive Anticoagulation for Cerebral Venous Sinus Thrombosis With SERPINC1 Mutation: A Case Report
por: Ma, Hongrui, et al.
Publicado: (2023)

CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathway [Corrigendum]
por: Feng, Z, et al.
Publicado: (2019)

Myeloid-derived suppressor cells regulate the immunosuppressive functions of PD-1(−)PD-L1(+) Bregs through PD-L1/PI3K/AKT/NF-κB axis in breast cancer
por: Liu, Min, et al.
Publicado: (2021)

PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways
por: Liu, Shengwei, et al.
Publicado: (2017)

PD‐1/PD‐L1 blockade rescue exhausted CD8+ T cells in gastrointestinal stromal tumours via the PI3K/Akt/mTOR signalling pathway
por: Zhao, Rui, et al.
Publicado: (2019)

Clinical implications of the interaction between PD-1/PD-L1 and PI3K/AKT/mTOR pathway in progression and treatment of non-small cell lung cancer
por: Quan, Zihan, et al.
Publicado: (2022)

Effect of STOX1 on recurrent spontaneous abortion by regulating trophoblast cell proliferation and migration via the PI3K/AKT signaling pathway
por: Li, Zhifang, et al.
Publicado: (2018)

PD-L1 Induces Epithelial–Mesenchymal Transition in Nasopharyngeal Carcinoma Cells Through Activation of the PI3K/AKT Pathway
por: Fei, Zhenghua, et al.
Publicado: (2019)

MM-129 as a Novel Inhibitor Targeting PI3K/AKT/mTOR and PD-L1 in Colorectal Cancer
por: Hermanowicz, Justyna Magdalena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r0m4h2og1pdsrrlsqohttnma06